Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Surgical Science Sweden

31.62 SEK

+0.38 %

Less than 1K followers

SUS

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Surgical Science Sweden

2019202020212022202320242025
Revenue101.5104.8366.8802.5882.9884.1992.3
growth-%3.2 %250.0 %118.8 %10.0 %0.1 %12.2 %
EBITDA30.437.090.0237.6244.8144.3152.3
EBIT15.220.056.5186.0189.2144.368.9
Profit before taxes12.619.765.8208.2268.3158.1100.1
Net income12.615.686.2188.0234.0131.766.8
EPS0.400.462.033.704.592.581.31
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%29.9 %35.3 %24.5 %29.6 %27.7 %16.3 %15.3 %
EBIT-%15.0 %19.1 %15.4 %23.2 %21.4 %16.3 %6.9 %
ROE3.1 %3.7 %2.4 %4.4 %5.4 %2.7 %1.6 %
ROI2.8 %3.3 %2.2 %4.0 %5.0 %2.4 %1.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.